These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. Shallis RM; Terry CM; Lim SH Am J Hematol; 2018 Jan; 93(1):122-128. PubMed ID: 28842931 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. van Lier YF; Vos J; Blom B; Hazenberg MD Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series. Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094 [TBL] [Abstract][Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics. Gray AN; DeFilipp Z Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290 [TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171 [TBL] [Abstract][Full Text] [Related]
13. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Henig I; Yehudai-Ofir D; Zuckerman T Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674 [TBL] [Abstract][Full Text] [Related]
14. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation. Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579 [TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation. Weber D; Meedt E; Poeck H; Thiele-Orberg E; Hiergeist A; Gessner A; Holler E Visc Med; 2024 Mar; 40(4):1-6. PubMed ID: 39047173 [TBL] [Abstract][Full Text] [Related]
16. [Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient]. Tamura S; Ishida H; Shimizu T; Imaeda H; Nishida A; Bamba S; Andoh A; Iwasa Y; Kuroda H Rinsho Ketsueki; 2022; 63(3):217-223. PubMed ID: 35387936 [TBL] [Abstract][Full Text] [Related]
17. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow. Docampo MD; Auletta JJ; Jenq RR Biol Blood Marrow Transplant; 2015 Aug; 21(8):1360-6. PubMed ID: 25708215 [TBL] [Abstract][Full Text] [Related]
18. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report. Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation]. Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190 [No Abstract] [Full Text] [Related]
20. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]